121 related articles for article (PubMed ID: 29698785)
1. Polyanionic holothurian glycosaminoglycans-doxorubicin nanocomplex as a delivery system for anticancer drugs.
Mou J; Wu Y; Bi M; Qi X; Yang J
Colloids Surf B Biointerfaces; 2018 Jul; 167():364-369. PubMed ID: 29698785
[TBL] [Abstract][Full Text] [Related]
2. Polyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations.
Yousefpour P; Atyabi F; Farahani EV; Sakhtianchi R; Dinarvand R
Int J Nanomedicine; 2011; 6():1487-96. PubMed ID: 21796249
[TBL] [Abstract][Full Text] [Related]
3. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded polypeptide nanorods based on electrostatic interactions for cancer therapy.
Zhang L; Zhang P; Zhao Q; Zhang Y; Cao L; Luan Y
J Colloid Interface Sci; 2016 Feb; 464():126-36. PubMed ID: 26609932
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
[TBL] [Abstract][Full Text] [Related]
6. The endocytic pathway and therapeutic efficiency of doxorubicin conjugated cholesterol-derived polymers.
Sevimli S; Sagnella S; Macmillan A; Whan R; Kavallaris M; Bulmus V; Davis TP
Biomater Sci; 2015 Feb; 3(2):323-35. PubMed ID: 26218123
[TBL] [Abstract][Full Text] [Related]
7. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
[TBL] [Abstract][Full Text] [Related]
8. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.
Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N
Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
10. N-Acetyl-D-glucosamine decorated polymeric nanoparticles for targeted delivery of doxorubicin: Synthesis, characterization and in vitro evaluation.
Tian B; Ding Y; Han J; Zhang J; Han Y; Han J
Colloids Surf B Biointerfaces; 2015 Jun; 130():246-54. PubMed ID: 25921641
[TBL] [Abstract][Full Text] [Related]
11. Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.
Nittayacharn P; Nasongkla N
J Mater Sci Mater Med; 2017 Jul; 28(7):101. PubMed ID: 28534285
[TBL] [Abstract][Full Text] [Related]
12. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
14. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Zhang B; Yang X; Wang Y; Zhai G
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
Wu J; Tang C; Yin C
Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
[TBL] [Abstract][Full Text] [Related]
16. A promising dual-drug targeted delivery system in cancer therapy: nanocomplexes of folate-apoferritin-conjugated cationic solid lipid nanoparticles.
Amer Ridha A; Kashanian S; Rafipour R; Hemati Azandaryani A; Zhaleh H; Mahdavian E
Pharm Dev Technol; 2021 Jul; 26(6):673-681. PubMed ID: 33896342
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
Wu J; Jiang W; Shen Y; Jiang W; Tian R
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
[TBL] [Abstract][Full Text] [Related]
18. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
[TBL] [Abstract][Full Text] [Related]
19. Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs.
Chen W; Zou Y; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
Biomacromolecules; 2014 Mar; 15(3):900-7. PubMed ID: 24460130
[TBL] [Abstract][Full Text] [Related]
20. The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles.
Yang C; Attia AB; Tan JP; Ke X; Gao S; Hedrick JL; Yang YY
Biomaterials; 2012 Apr; 33(10):2971-9. PubMed ID: 22244697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
